| __timestamp | ADMA Biologics, Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 5915545 | 64538000 |
| Thursday, January 1, 2015 | 7177633 | 71914000 |
| Friday, January 1, 2016 | 10661037 | 108973000 |
| Sunday, January 1, 2017 | 22760560 | 141102000 |
| Monday, January 1, 2018 | 16985290 | 251453000 |
| Tuesday, January 1, 2019 | 29349083 | 120282000 |
| Wednesday, January 1, 2020 | 42219783 | 186419000 |
| Friday, January 1, 2021 | 80942625 | 277133000 |
| Saturday, January 1, 2022 | 154079692 | 196245000 |
| Sunday, January 1, 2023 | 258214999 | 131314000 |
Cracking the code
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success. Over the past decade, ADMA Biologics, Inc. and Ligand Pharmaceuticals Incorporated have showcased contrasting revenue trajectories. ADMA Biologics has experienced a remarkable surge, with its revenue skyrocketing by over 4,200% from 2014 to 2023. This growth reflects the company's strategic advancements and market expansion.
Conversely, Ligand Pharmaceuticals, while maintaining a strong revenue base, has seen a more modest growth of approximately 100% over the same period. Notably, Ligand's peak revenue in 2021 was nearly double that of ADMA's, highlighting its established market presence. However, by 2023, ADMA's revenue had surpassed Ligand's, marking a significant shift in the competitive landscape. This data underscores the evolving dynamics in the biotech sector, where innovation and adaptability are paramount.
Dr. Reddy's Laboratories Limited and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Jazz Pharmaceuticals plc vs ADMA Biologics, Inc.: Annual Revenue Growth Compared
Halozyme Therapeutics, Inc. and ADMA Biologics, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Halozyme Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Performance Compared
Revenue Insights: Grifols, S.A. and Ligand Pharmaceuticals Incorporated Performance Compared
Who Generates More Revenue? Cytokinetics, Incorporated or Ligand Pharmaceuticals Incorporated
Revenue Insights: Alkermes plc and Ligand Pharmaceuticals Incorporated Performance Compared
Breaking Down Revenue Trends: ADMA Biologics, Inc. vs Perrigo Company plc
ADMA Biologics, Inc. vs Ligand Pharmaceuticals Incorporated: SG&A Expense Trends
ADMA Biologics, Inc. and Galapagos NV: A Comprehensive Revenue Analysis
Ligand Pharmaceuticals Incorporated or Travere Therapeutics, Inc.: Who Leads in Yearly Revenue?
Annual Revenue Comparison: Ligand Pharmaceuticals Incorporated vs Evotec SE